Mary Ackerley, MD, MD(H), ABIHM

ISEAI President

Mary Beth Ackerley, MD, MD(H), ABIHM, is a classically trained board certified psychiatrist. She is a Summa Cum Laude graduate of Harvard University (BA), studied at NIMH, finished her residency at Johns Hopkins and was certified in Psychiatry and Neurology. She holds active medical licenses in Arizona and Florida. She is a gifted speaker and board certified in Integrative and Holistic Medicine. She is a member of the Arizona Homeopathic and Integrative Medical Association.

She is the co-founder of ISEAI. Society members are dedicated to researching and quantifying symptoms and treatment approaches from biotoxin mediated inflammatory illness.

As an integrative holistic physician, she specializes in natural treatments. Patients commonly see her for anxiety, depression, brain fog and chronic fatigue. Her skills include the ability to manage cognitive and psychiatric symptoms often found in complex chronic illness. Protocols for biotoxin illness may involve conventional and integrative medical treatment.

Dr. Ackerley recognized a significant relationship between methicillin resistant nasal pathogens and hidden dental infections known as cavitations. It is her hope that understanding the neuro-inflammatory biotoxin link to psychiatry may bring greater improvements in research, diagnosis and treatment in the future.

Oxygen malabsorption and chronic fatigue are shown to link with biotoxin illness. The brain requires a steady supply of energy, and poor absorption of oxygen leads to physical debilitation and exhaustion, with a subsequent inability to accomplish simple daily tasks. The inability to utilize oxygen effectively may be a major cause of brain fog, cognitive impairment, anxiety and emotional lability often seen in chronic fatigue patients.

New research is evolving in the earlier detection and potential reversal of Alzheimer’s Disease. Our current understanding of AD is being assisted using traditional MRI brain scans in conjunction with a newly developed diagnostic software tool called the NeuroQuant Triage Brain Atrophy Report. Triage reports can pinpoint brain regions that may underlie neuropsychiatric symptoms. Dr. Ackerley has presented these findings at medical conferences.

Her internet article entitled “Brain on Fire” (related YouTube) is a summary of the psychiatric implications of biotoxin illness and her practice My Passion 4 Health is located in Arizona. She may be reached for consultations on complex cases through Skype.

Learn more:

2019 ISEAI Conference Lectures

Friday, May 3 4:45 pm – 5:15 pm

Lecture Highlights:

  • Why do we treat MARCoNS? What evidence is there that links the treatment of MARCoNS to CIRS?
  • What is “Treatment Resistant MARCoNS”?  When do you decide treatment is making infection worse, not better?
  • What is Dental MARCoNS? How is it diagnosed and treated?
  • What are the currently acceptable treatments for MARCoNS?
  • What about household partners and animals?
  • Can a patient get well without eradicating MARCoNS?

Sunday, May 5 8:30 am – 10:00 am
Diagnosis and Treatments Unique to Psychological Aspects of Environmentally Acquired Illness (EAI) Including NeuroQuant and Mast Cell Activation

Lecture Highlights:

  • The brain takes a major hit in inhalational toxicity. More than half the symptoms commonly seen are neurological, cognitive or psychiatric.
  • Neuroinflammation, or microglial activation, can progress to neurodegeneration
  • NeuroQuant is a useful tool for assessing the neuropsychiatric impact of CIRS and Lyme. Patients appreciate validation of their symptoms as “real” and it can be useful in disability claims.
  • We will look at examples of its usefulness in Alzheimer’s, Traumatic Brain Injury, Limbic Dysregulation and PANS
  • We will discuss multiple treatment approaches that have been found useful for improving neuroinflammation and degeneration
Mary Ackerley, MD